Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions

Abstract

Cell and immunotherapy products are known for targeting the root cause of health ailments and potentially curing cancers and other degenerative indications. The rapid growth in cell therapy products, CRISPR-based gene editing, and stem cell applications in India is changing the face of personalized medicine, putting the country at the forefront of innovative product development. The therapy develops through strong regulatory guidelines and collaborative efforts among academia, industry, and government. However, high costs, less infrastructure, regulatory complexity, and ethics are hurdles in implementing the idea. This review emphasizes the progress made in cell therapy research in India and discusses the challenges as well as the possible strategies for overcoming them.